Original language | English (US) |
---|---|
Pages (from-to) | 105 |
Number of pages | 1 |
Journal | Seminars in reproductive medicine |
Volume | 37 |
Issue number | 3 |
DOIs | |
State | Published - May 23 2019 |
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Reproductive Medicine
- Endocrinology
- Obstetrics and Gynecology
- Physiology (medical)
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Seminars in reproductive medicine, Vol. 37, No. 3, 23.05.2019, p. 105.
Research output: Contribution to journal › Editorial › peer-review
TY - JOUR
T1 - Waljit SDhillo, MD
AU - Legro, Richard S.
N1 - Funding Information: He completed his medical training at St Bartholomew’s Hospital Medical School, University of London, in 1994. During this time, he also completed an intercalated BSc in biochemistry (awarded first class honors) funded by the Medical Research Council. He then completed his general medical training in London Hospitals. In 1997, he joined the North West Thames Rotation in Diabetes and Endocrinology as a specialist registrar. During this time, he completed a PhD on the area of novel neuropeptides regulating appetite as a Wellcome Trust Clinical Training Fellow at Imperial College with Professor Sir Steve Bloom. In 2004, he was awarded a NIHR Clinician Scientist Fellowship and appointed Clinical Senior Lecturer and Consultant in Diabetes and Endocrinology at Imperial College London. Following this, he was awarded an NIHR Career Development Fellowship and promoted to Reader in 2009. In 2011, he was promoted to Professor in Endocrinology and Metabolism. In 2015, Prof. Dhillo was awarded the prestigious NIHR Research Professorship. Funding Information: Prof. Dhillo’s recent translational research has identified the novel hormone kisspeptin as a potential novel therapy for infertility. He has performed the “first time into human” studies of kisspeptin. He has shown that kisspeptin potently stimulates reproductive hormone release in human male and female volunteers. This work was awarded the American Endocrine Society Award for Excellence in Clinical Research and the British Society for Neuroscience Investigator Prize. He has also shown that kisspeptin administration potently increased reproductive hormone release in women with infertility due to hypothalamic amenorrhea. Recently, Prof. Dhillo has shown for the first time in women with infertility that kisspeptin can be used safely and effectively in in vitro fertilization treatment. He was been awarded the Royal College of Physicians Goulstonian Lectureship (2010) and the Society for Endocrinology Medal (2015) for this work.
PY - 2019/5/23
Y1 - 2019/5/23
UR - http://www.scopus.com/inward/record.url?scp=85077206182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077206182&partnerID=8YFLogxK
U2 - 10.1055/s-0039-3403460
DO - 10.1055/s-0039-3403460
M3 - Editorial
C2 - 31869836
AN - SCOPUS:85077206182
SN - 1526-8004
VL - 37
SP - 105
JO - Seminars in reproductive medicine
JF - Seminars in reproductive medicine
IS - 3
ER -